Allgens Financial Statements From 2010 to 2024

Stocks . China . 
Stock . Allgens Medical Technology
688613 Stock   17.93  0.03  0.17%   
Allgens Medical financial statements provide useful quarterly and yearly information to potential Allgens Medical Technology investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Allgens Medical financial statements helps investors assess Allgens Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Allgens Medical's valuation are summarized below:
Gross Profit
204.5 M
Profit Margin
0.0267
Market Capitalization
2.4 B
Enterprise Value Revenue
7.4602
Revenue
191.2 M
We have found sixty-nine available fundamental signals for Allgens Medical Technology, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Allgens Medical Technology prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Allgens Medical Total Revenue

200.4 Million

Check Allgens Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Allgens Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.6 M, Interest Expense of 1.7 M or Selling General Administrative of 92.6 M, as well as many indicators such as . Allgens financial statements analysis is a perfect complement when working with Allgens Medical Valuation or Volatility modules.
  
This module can also supplement various Allgens Medical Technical models . Check out the analysis of Allgens Medical Correlation against competitors.

Allgens Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.1 B1.5 B672.4 M
Slightly volatile
Other Current Liabilities291.6 K307 K21.2 M
Slightly volatile
Total Current Liabilities60 M50.8 M33.3 M
Slightly volatile
Total Stockholder Equity917 M1.4 B595.9 M
Slightly volatile
Property Plant And Equipment Net177.8 M186.6 M107.2 M
Slightly volatile
Accounts Payable5.2 M10.4 M2.6 M
Slightly volatile
Cash161.6 M161.3 M85.4 M
Slightly volatile
Non Current Assets Total257.9 M325.5 M155.7 M
Slightly volatile
Non Currrent Assets Other4.6 M4.9 M18.6 M
Slightly volatile
Cash And Short Term Investments1.3 B1.2 B387.6 M
Slightly volatile
Common Stock Shares Outstanding120.2 M133.3 M96.9 M
Slightly volatile
Liabilities And Stockholders Equity960.4 M1.7 B674.7 M
Slightly volatile
Inventory20 M32.7 M17.1 M
Slightly volatile
Other Current Assets29.7 M31.3 M147 M
Slightly volatile
Other Stockholder Equity625.8 M1.1 B480.2 M
Slightly volatile
Total Liabilities125.5 M122.6 M65.5 M
Slightly volatile
Total Current Assets807.2 M1.2 B516.7 M
Slightly volatile
Intangible Assets24.9 M22.1 M15.5 M
Slightly volatile
Common Stock95.1 M153.3 M63.1 M
Slightly volatile
Non Current Liabilities Total76.5 M71.8 M39.2 M
Slightly volatile
Short and Long Term Debt Total66.2 M70.8 M53.1 M
Slightly volatile
Long Term Debt38.6 M45.4 M44.9 M
Pretty Stable
Net Receivables34.8 M59.3 M21 M
Slightly volatile
Short Term Investments708.9 M902.2 M489.6 M
Slightly volatile
Net Invested Capital1.2 B1.4 B784.5 M
Slightly volatile
Short and Long Term Debt9.9 M5.1 M5.3 M
Slightly volatile
Capital Stock132 M153.3 M110.1 M
Slightly volatile
Net Working Capital923.1 M1.1 B583.3 M
Slightly volatile
Short Term Debt11 M18 M6.2 M
Slightly volatile
Capital Lease Obligations3.8 M3.4 M2.7 M
Slightly volatile
Property Plant And Equipment Gross267.4 M251.5 M244.8 M
Slightly volatile

Allgens Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense1.7 M3.1 M999.1 K
Slightly volatile
Selling General Administrative92.6 M88.2 M23.3 M
Slightly volatile
Selling And Marketing Expenses19.1 M36 M15 M
Slightly volatile
Total Revenue200.4 M226.5 M141 M
Slightly volatile
Gross Profit167 M187.2 M115.9 M
Slightly volatile
Other Operating Expenses114 M186.3 M91.2 M
Slightly volatile
Operating Income31.2 M32.9 M48.4 M
Slightly volatile
EBIT87.1 M110.8 M57.8 M
Slightly volatile
Research Development32.2 M45.5 M21.6 M
Slightly volatile
EBITDA92.8 M122.8 M63.1 M
Slightly volatile
Cost Of Revenue33.4 M39.2 M25.1 M
Slightly volatile
Total Operating Expenses100.9 M193.6 M70.5 M
Slightly volatile
Income Before Tax81 M49.1 M52.6 M
Slightly volatile
Net Income76 M54.2 M48.3 M
Slightly volatile
Income Tax Expense10 M5.2 M6.5 M
Slightly volatile
Interest Income3 M3.3 M1.4 M
Slightly volatile
Net Income From Continuing Ops66.2 M53 M70.5 M
Slightly volatile
Reconciled Depreciation15.5 M18 M12.1 M
Slightly volatile
Minority Interest2.1 M1.3 M3.2 M
Slightly volatile

Allgens Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow139.8 M259.9 M79.5 M
Slightly volatile
Depreciation12.7 M18 M8.3 M
Slightly volatile
Dividends Paid11.3 M17.1 M5.1 M
Slightly volatile
Capital Expenditures20.8 M21.9 M41.8 M
Pretty Stable
Total Cash From Operating Activities89.5 M51.7 M59.4 M
Slightly volatile
Net Income73.3 M54.2 M47 M
Slightly volatile
End Period Cash Flow161.4 M161.3 M85.3 M
Slightly volatile

About Allgens Medical Financial Statements

Allgens Medical stakeholders use historical fundamental indicators, such as Allgens Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Allgens Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Allgens Medical's assets and liabilities are reflected in the revenues and expenses on Allgens Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Allgens Medical Technology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue226.5 M200.4 M
Cost Of Revenue39.2 M33.4 M

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Allgens Stock

Allgens Medical financial ratios help investors to determine whether Allgens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allgens with respect to the benefits of owning Allgens Medical security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY